EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction

Md Torikul Islam iD, Shelby A Hall, Tavia Dutson, Samuel I Bloom iD, R Colton Bramwell, John Kim, Jordan R Tucker, Daniel R Machin iD, Anthony J Donato, Lisa A Lesniewski

Aging Cell · 2024

DOI: 10.1111/acel.14040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Md Torikul Islam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Integrative Physiology, The University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Vasodilation, Endothelium, Vascular. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIA NIH HHS, NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic inhibition of the mammalian target of rapamycin (mTOR) delays aging and many age‐related conditions including arterial and metabolic dysfunction. However, the mechanisms and tissues involved in these beneficial effects remain largely unknown. Here, we demonstrate that activation of S6K, a downstream target of mTOR, is increased in arteries with advancing age, and that this occurs preferentially in the endothelium compared with the vascular smooth muscle. Induced endothelial cell‐specific deletion of mTOR reduced protein expression by 60–70%. Although this did not significantly alter arterial and metabolic function in young mice, endothelial mTOR reduction reversed arterial stiffening and improved endothelium‐dependent dilation (EDD) in old mice, indicating an improvement in age‐related arterial dysfunction. Improvement in arterial function in old mice was concomitant with reductions in arterial cellular senescence, inflammation, and oxidative stress. The reduction in endothelial mTOR also improved glucose tolerance in old mice, and this was associated with attenuated hepatic gluconeogenesis and improved lipid tolerance, but was independent of alterations in peripheral insulin sensitivity, pancreatic beta cell function, or fasted plasma lipids in old mice. Lastly, we found that endothelial mTOR reduction suppressed gene expression of senescence and inflammatory markers in endothelial‐rich (i.e., lung) and metabolically active organs (i.e., liver and adipose tissue), which may have contributed to the improvement in metabolic function in old mice. This is the first evidence demonstrating that reducing endothelial mTOR in old age improves arterial and metabolic function. These findings have implications for future drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VasodilationEndothelium, VascularAnimalsMiceAgingArteriesOxidative StressTOR Serine-Threonine KinasesEndothelial CellsSirolimusMammals

Stichwörter der Autor:innen

agingarterial stiffnessendothelial cellsinflammationmetabolic functionoxidative stresssenescencevasodilation

Substanzen

TOR Serine-Threonine KinasesSirolimus

Autor:innen und Institutionen

  • Department of Nutrition and Integrative Physiology, The University of Utah, Salt Lake City, Utah, USA.
  • Division of Geriatrics, Department of Internal Medicine, The University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Nora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Geriatric Research Education and Clinical Center, Veteran's Affairs Medical Center, Salt Lake City, Utah, USA.
  • Department of Biochemistry, The University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Md Torikul Islam, Samuel I Bloom, Daniel R Machin

Förderung

  • BLRD VA
  • NIA NIH HHS
  • NCCIH NIH HHS

Zitieren

APA

Islam, M. T., Hall, S. A., Dutson, T., Bloom, S. I., Bramwell, R. C., Kim, J., Tucker, J. R., Machin, D. R., Donato, A. J., & Lesniewski, L. A. (2024). Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction. Aging Cell. https://doi.org/10.1111/acel.14040

Vancouver

Islam MT, Hall SA, Dutson T, Bloom SI, Bramwell RC, Kim J, et al. Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction. Aging Cell. 2024. doi:10.1111/acel.14040

BibTeX
@article{Islam2024,
  author = {Islam, Md Torikul and Hall, Shelby A and Dutson, Tavia and Bloom, Samuel I and Bramwell, R Colton and Kim, John and Tucker, Jordan R and Machin, Daniel R and Donato, Anthony J and Lesniewski, Lisa A},
  title = {Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction},
  journal = {Aging Cell},
  year = {2024},
  doi = {10.1111/acel.14040}
}
Kostenlos starten →